Abstract Details
| Mark Wainwright, MD, PhD, FAAN (Division of Neurology Seattle Childrens Hospital) | Dr. Wainwright has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sage Therapeutics. |
| Kelly Sullivan, PhD (Georgia Southern University) | Dr. Sullivan has received intellectual property interests from a discovery or technology relating to health care. |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file |